Kestrel Therapeutics Inc. (“Kestrel” or the “Company”), a clinical stage biotechnology company developing next-generation ...
Researchers at Skoltech have developed an ultra-compact electro-optic modulator based on silicon photonics and plasmonics ...
Hosted on MSN
Fenebrutinib outperforms Aubagio in major MS trials
Fenebrutinib, an experimental oral BTK inhibitor, significantly reduced relapse rates and MRI markers of disease activity compared with Aubagio in two large Phase 3 trials for relapsing multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results